1. Introduction
Background
Epilepsy accounts for up to 1% of the global burden of disease. 2 An estimated 32.7 million people suffer from active epilepsy worldwide, 3 with 80% or more of people with epilepsy (PWE) living in low and middle income countries (LMICs). 4 A further 500 million people (including families and carers of PWE) are thought to be indirectly affected by epilepsy. 5 It is generally accepted that the incidence, prevalence and mortality associated with epilepsy are all higher in LMICs than in high income countries (HICs), although estimates have varied widely and findings from different studies are difficult to compare due to differing inclusion criteria, clinical definitions and the difficulties associated with establishing reliable baseline demographic data. 3, [6] [7] [8] [9] While up to four-fifths of the potential market for anti-epileptic drugs (AEDs) is in LMICs, 90% or more of PWE in these countries may receive no treatment at all. 5, 10, 11 The proportion of PWE who require treatment but who are not receiving it is known as the treatment gap (TG).
Objectives
We conducted a door-to-door survey in an established demographic surveillance site (DSS) in rural Tanzania. We sought to estimate the prevalence of active epilepsy, to describe the pattern of epilepsy and to quantify the TG in this population. With a total denominator population of 161,119, this is one of the largest community-based epidemiological studies of epilepsy to be conducted in sub-Saharan Africa (SSA) to date. Paediatric and adult studies were conducted in parallel. Findings from the paediatric population have been published elsewhere 13 ; we report here on findings in the adult population, defined as individuals aged 15 years and above.
Methods

Study design
A door-to-door census of the entire DSS population was completed between January and June 2009 and a previously validated screening questionnaire was used to detect possible cases of epilepsy. 1 The questionnaire was forward and back translated between English and Kiswahili (KS) and a pilot study was conducted to assess the questionnaire's sensitivity for cases of epilepsy in a KS-speaking Tanzanian population. Volunteers for the pilot study included patients with and without epilepsy at Muhimbili National Hospital, Dar es Salaam, and locally at Kilimanjaro Christian Medical Centre (KCMC), Moshi. During preparations for the census, all enumerators received training in the identification of likely cases of epilepsy and were also involved in focus group discussions of each item in the screening questionnaire, with further refinements to the KS translation being made to optimise its utility in the field. Details of the screening questionnaire and KS translation are given in Appendix.
Study setting
The Hai district lies on the slopes of Mount Kilimanjaro in northeast Tanzania, covering an area of approximately 13,000 km 2 .
Villages are served by a network of unpaved roads of varying quality, many of which are impassable to motorised vehicles during the twice-yearly rainy seasons. Agriculture, livestock keeping, dairy farming, commercial mining and cottage industries are the main economic activities. 14 Facilities for Electroencephalography (EEG) and computed tomography (CT) are available at KCMC, a large referral hospital in the nearby town of Moshi.
Hai was established as one of three DSSs in Tanzania by the Adult Morbidity and Mortality Project (AMMP), an epidemiological programme funded by the UK Department for International Development and conducted in partnership between the Tanzanian Ministry for Health and Newcastle University, UK. 15 Between 1992 and 2004 the population of each DSS was enumerated by an annual census, with all households and household members being assigned unique identifying numbers. The DSS infrastructure in Hai has subsequently been maintained through a series of epidemiological studies, and there is currently at least one trained census enumerator per village. [16] [17] [18] [19] [20] [21] These enumerators facilitate access to their communities by visiting researchers and are coordinated by a team of supervisors who are employed in clinical posts by the district health authority.
Participants and data sources
All individuals who responded positively to the screening questionnaire at census were assessed in detailed by a research doctor trained in the diagnosis of epilepsy (EH). In addition, enumerators were also asked to identify any individuals within their communities who they knew, or suspected, suffered from a seizure disorder. Finally, results of a contemporaneous study utilising data from the same census to screen for neurological disability, including epilepsy, in 2232 individuals aged over 70 provided further cases. 21 A collateral history was sought in all instances to aid in diagnosis and classification of seizures. To be included in the study people diagnosed with epilepsy had to be alive and resident in the district on the prevalence date. The age cut-off for adults of 15 years and above was chosen to reflect local practice in terms of whether individuals are managed by adult or paediatric medical services.
Variables
All individuals diagnosed with epilepsy were interviewed in depth to establish seizure history, possible risk factors, treatment history and socio-demographic features. The interview format was drawn from the clinical experience of the research team and from previous field work experience in this study population. 16, 18, 22 A semistructured element was included to facilitate subsequent review and validation of diagnoses. 23 All cases were offered further investigation with CT head scan and EEG. CT scans were reported locally to exclude any acute pathology, and then reviewed by neuroradiologists in the UK (DB, AI). There are no facilities for interpreting EEGs locally and all recordings were read in the UK by a consultant neurophysiologist (RGW). Any individuals identified with epilepsy who were not being treated adequately were started on treatment and referred to services locally for follow-up. Clinical details and investigation findings for all patients were reviewed by a consultant neurologist in the UK with an interest in epilepsy (MJ). CT and EEG findings were correlated with clinical details to classify epilepsies according to currently accepted criteria. 24, 25 Active epilepsy was defined as at least two unprovoked seizures occurring at least 24 h apart, with the most recent seizure occurring within the 5 years prior to the prevalence date of 1st of June 2009. Individuals who did not satisfy these criteria, but who were maintained on AEDs for an appropriate indication, were also considered to have active epilepsy. Estimates for the TG were based on individuals who reported either no or inadequate AED therapy at the time of the study. All data were entered into Microsoft Excel 2007 as field work progressed and then re-entered into Microsoft Access 2007, with any discrepancies being corrected with reference to the original case notes.
Statistical methods
Statistical analyses were performed using SPSS-17 for Windows (SPSS, Chicago, IL, USA). Age-and sex-specific prevalence rates for the Hai adult population were calculated in five-year age-bands. Prevalence was age-standardised to the WHO world standard population using the direct method 26 ; 95% confidence intervals (CIs) were calculated based on the assumptions of the binomial distribution. As this study is concerned only with individuals aged 15 years and above, the Hai and WHO populations were weighted accordingly (Table 5 ). To look for any evidence of clustering, oneway analysis of variance (ANOVA) was used to compare normally distributed mean prevalences from administrative divisions within the district.
Results
Pilot study
Forty-nine subjects (27 cases of epilepsy and 22 controls) were recruited into the pilot study. The KS translation of the screening questionnaire performed with 100% sensitivity and 54.5% specificity, with positive and negative predictive values (PPV, NPV) of 73% and 100% respectively.
Participants
The 2009 census identified a total population of 161,119, of whom 103,026 (63.9%) were aged 15 years and over (54,386 female, 48,640 male) ( Fig. 1) . Five hundred and sixty-eight adult individuals (286 female, 282 male) responded positively to the screening questionnaire. Response rates to individual questions are given in Table 1 . Three hundred and ninety-five (69.5%) of these were clinically assessed, with a diagnosis of active epilepsy being made in 209 (PPV 52.9%). Of the 173 individuals that were not available for assessment, 29 (16.8%) had moved or travelled from the district at the time of the study, 21 (12.1%) could not be traced, 18 (10.4%) refused, 12 (6.9%) had died since the census (four deaths prior to the prevalence date) and four (2.3%) were accounted for by data entry errors (duplicate names or wrong dates of birth). A further 89 (51.4%) did not attend for assessment on two or more occasions. In addition to census responders, a further 130 individuals (60 female, 70 male) identified by village enumerators as possible cases were assessed, with active epilepsy being diagnosed in 80 (61.5%). The concurrent study of neurological disability in the elderly identified five cases of active epilepsy, of which one was identified independently by the epilepsy study, with a further two being available for assessment and inclusion in the final case series. Epilepsy was suspected in a further 14 individuals, although insufficient history was obtained, either directly or from an eye witness, to confirm the diagnosis. These individuals remain under follow-up. In summary, 527 individuals were assessed clinically with 291 cases of active epilepsy being identified (Fig. 2 ). An eye witness was available in 202 (69.4%) of 291 confirmed cases. CT head scans were available in 200 (68.7%) of 291 confirmed cases, with cerebral abnormalities on 51 (25.5%) scans. EEGs were available from 216 (74.2%) of 291 cases, with abnormalities consistent with epilepsy seen in 84 (38.9%) recordings. CT and EEG findings are summarised in Tables 2 and 3 .
Clinical features and treatment history
All 291 cases identified were suffering from active epilepsy with convulsive seizures (AEWCS). Focal onset seizures were identified Table 6 ). The relative contributions of diagnostic modalities to identifying focal onset seizures are illustrated in Fig. 3 . Two-hundred and fifty-three (86.9%) of 291 cases had previously sought medical attention for their seizures, of whom 122 (48.2%) reported using AEDs at the time of the study. Of these, 30 (24.6%) were using doses likely to be sub-therapeutic, based on published prescribing information 27, 28 and guidance on managing epilepsy in resource-poor settings. 29 Ninety-two (31.6%) of 291 cases were therefore considered as adequately treated with AEDs at the time of the study.
Prevalence and treatment gap
The crude prevalence of AEWCS in the Hai adult population on 1st June 2009 was 2.82 per 1000 adults (95% CI 2.50-3.15). Ageand sex-specific prevalence rates are given in Table 4 . The crude prevalence was higher in males than in females (difference in proportions 0.69/1000; 95% CI 0.03-1.34). To accommodate small numbers in the older population, cases aged 70 years or more were combined into a single age band of 70+ prior to age-standardisation ( Table 5 ). The age-standardised prevalence of AEWCS in the adult Hai population was 2.91 per 1000 adults (95% CI 2.58-3.24). After accounting for deaths prior to the prevalence date and data entry errors, a further 165 (95.4%) of the 173 individuals who screened positive during the census but who were not assessed clinically were potentially eligible for the study. Applying the PPV of 52.9% for detection of active epilepsy by the screening questionnaire, an additional 87 cases may have been missed, which would bring the total number of active cases to 378 (crude prevalence 3.67 per 1000; 95% CI 3.3-4.0). Diagnoses were deferred in 14 individuals and two cases identified by the other study were not available for assessment by the epilepsy study team. A confirmed diagnosis in these 16 would bring the total case series to 394 (crude prevalence 3.82 per 1000; 95% CI 3. 45-4.20) . While the prevalence of epilepsy varied from village to village (0-6.24/1000), there were no significant differences in mean prevalence between the five administrative divisions within the district (ANOVA, p = 0.991).
A conservative estimate of the TG for epilepsy in the adult Hai population, based on AED use, was 68.4% (95% CI 63.0-73.7).
Discussion
Key results and interpretation
This study is one of the largest community-based surveys of the prevalence of epilepsy in an adult population to be conducted in SSA to date. The age-standardised prevalence for AEWCS in adults of 2.91/1000 (95% CI 2.58-3.24), with crude prevalence adjusted for non-response of 3.84/1000 (95% CI 3.47-4.22), is considerably lower than both the median prevalence of 15/1000 previously reported from SSA 9 and the range for active prevalence of 8-10/ 1000 previously reported from Tanzania. [30] [31] [32] It is, however, in line with a recent study of comparable size and design in a rural Kenyan population which found a crude prevalence of 2.9/1000 (95% CI 2.6-3.2), rising to 4.5/1000 (95% CI 4.1-4.9) after adjustment for non-response and sensitivity. 33 This latter study sought to identify active convulsive epilepsy only, and the lower prevalence figures of both studies may reflect this. In community-based studies from SSA heterogeneity of prevalence within study populations has been frequently observed. 9, 31, 33 Whether this reflects clustered exposure to environmental or genetic risk factors or a tendency for PWE to live closer to locally available treatment services remains unclear. In our study case ascertainment was grossly uniform across administrative divisions, with no observation of clustering. We found a higher prevalence in males than in females, although the difference was marginal. A review of 19 studies of the prevalence in SSA in which data on gender were available found a mean ratio of males to females of 1.4, although the ratio was significantly different in only a quarter of studies. 9 It has been suggested that a higher prevalence of epilepsy in males in Tanzania may reflect a higher risk of cranial trauma through a tendency to engage in more dangerous occupations. 32 Conversely, other studies from Tanzania have found higher proportions of females with epilepsy. 30, 31 It has been postulated that this may be accounted for by a higher mortality rate among males, again because of dangerous occupations, 31 although Tanzania is a country with a high maternal mortality rate, and the strength of this argument could be questioned. 34 It has been observed that women in one study population were more health-conscious then men, being accustomed to attending maternity and child-care clinics and speaking openly about health issues, possibly contributing to higher ascertainment rates in women. 30 Overall there remains no clear consensus on whether observed gender differences in the prevalence of epilepsy in SSA are due to genderspecific aetiological factors, bias arising through artefact in caseascertainment or competing mortality risks. 35 Studies from Europe and the USA have identified peaks in the incidence of epilepsy in young children and in the elderly. [36] [37] [38] We did not find a peak in prevalence in those aged 60 and older, although this age group represents only 10.6% of the total Hai population, and it is difficult to draw comparisons with populations from HICs which have very different population structures. We did find a peak in prevalence in those aged 20-24 years (6.13/1000), with a concentration of male cases in this age group (crude prevalence in males 7.63/1000). This is in keeping with a higher prevalence in adolescents and young adults identified by other studies in rural SSA. 9, [30] [31] [32] [33] Whether the lower prevalence in later adult life points to early mortality or spontaneous remission remains unclear. 33 A similar distribution in both the active and lifetime prevalence of epilepsy has been observed in Tanzania, suggesting that those in remission may not report their previous seizures. 31, 39 Conversely, there is mounting evidence of early mortality in epilepsy in LMICs, in excess of that seen in HICs. 40 Observational data suggest that this is likely to be the case in SSA, [41] [42] [43] although there are very few formalised data with comparable standardised mortality ratios. 43 All PWE identified in our study had AEWCS, with focal-onset seizures accounting for 71.5% of all cases. High rates of focal onset seizures were found in 71% of all cases identified in a recent community-based study of people with AEWCS in Kenya, 44 and in 55% of all cases in a community-based study from Nigeria, although it is not clear how focal seizures with generalised clonic movements were classified in this latter study. 45 Conversely, higher rates of generalised-onset seizures have previously been reported from community-based studies in SSA, accounting for between 58% and 82% of diagnoses. 31, 32, 46 Differing approaches to case-ascertainment, differing diagnostic and classification criteria, and lack of EEG and CT to aid with classification make a strict comparison between studies difficult, although all authors comment that focal seizures becoming rapidly generalised may have erroneously been classified as generalised onset seizures. The high rate of focal onset seizures identified in our study suggests that a high proportion of epilepsy in this population may be due to identifiable, and possibly preventable, causes. We know that epilepsy in children from Hai is associated with adverse perinatal events 13 , while exposure to Taenia solium, the parasitic infection responsible for neurocysticercosis (NCC), is associated with epilepsy in a number of African populations, 47 including Tanzania. 48, 49 The role that this latter aetiology might play in an area where the prevalence of epilepsy is low, such as Hai, is not clear, and further investigation of risk factors in this population is warranted.
The TG for epilepsy in the Hai population, based on reported use of adequate and appropriate AED therapy, was 68.4% (95% CI 63.0-73.7). This is lower than previous estimates of TG in Tanzania of between 76% and 95.8%, 30, 32 although is in line with more recent systematic reviews of TG in developing countries worldwide. 12, 50 The lower TG in Hai could be explained by the relative proximity to a large referral hospital (KCMC) and to the nearby large towns of Arusha and Moshi, where numerous private clinics and non-governmental healthcare providers are located. Conversely, we know that there is a high degree of stigma associated with epilepsy in this population, 20 and more stigmatised and marginalised individuals may not have presented to the study. It can be assumed that such individuals would be less likely to be treated, and would therefore contribute to the estimate of TG if they were known.
Limitations
While a small pilot study established the sensitivity of the screening tool in a KS-speaking Tanzanian population, a fieldbased validation study with complete ascertainment in a larger sample would have facilitated a sensitivity analysis of the screening questionnaire and would also have allowed us to comment on the likely prevalence of non-convulsive epilepsies, given that these were not detected by our screening protocol. Epilepsy with non-convulsive seizures can account for up to 50% of all epileptic disorders in community-based studies, and the true prevalence of all epilepsies in the Hai population may therefore approach 6/1000. 36, 37 Only cases of generalised convulsive epilepsy were detected in our study, despite the aim of detecting all seizure types. Community-based studies from Zambia and Tanzania have also made use of the same screening instrument, with modifications. In Zambia, three additional questions were used to reduce the falsepositive rate due to detection of febrile and malaria-associated seizures in children under the age of seven years. 35 The paediatric study from Hai excluded children under the age of six years for this reason, 13 and these additional questions were not used in our study. In Tanzania, a 15-item questionnaire has been used, 30 although results of this study were not available at the time of planning and initiating our population census. We anticipated difficulties with specific questions, particularly questions two and eight (see Appendix), and sought to address these through focus group work with census enumerators administering the questionnaire. The difficulties of identifying focal onset epilepsies without secondary generalisation in community-based studies in SSA have previously been acknowledged and reflected in study design. 33 Based on our experience, it may be that this is a more realistic approach for large-scale surveys conducted in SSA. Nearly one third of individuals (30.5%) who responded positively to the screening questionnaire were not available for clinical assessment. While this decreases the internal validity of our study, and must be acknowledged as a limitation, Hai is an established DSS, and this high rate of non-attendance may also reflect the high degree of stigma associated with epilepsy in this population. 20 The use of capture-recapture techniques has previously been used to maximise case ascertainment of noncommunicable diseases in a clinic-based setting in South Africa, 51 although has been less successful in community-based settings in Tanzania, including Hai, 52 and was not pursued in our study. While we report here on the prevalence in adults only, the estimate has been age-standardised to facilitate comparison with other studies. The crude prevalence in children over the age of six years in the same population was 2.91 per 1000. 13 
Conclusions
Active epilepsy with convulsive seizures has a lower prevalence in this part of Tanzania than elsewhere in SSA, and the previously reported high prevalence rates for epilepsy in SSA cannot be generalised to the whole region. The high proportion of focal onset seizures points to a large burden of acquired, and possibly preventable, epilepsy. The treatment gap of 68.4% confirms that interventions to improve the management of epilepsy in this population are warranted. With a low prevalence, however, improved outcomes are potentially achievable for the majority of PWE in this and similar populations. 
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Je, ulishawahi kupatwa na hali ya kutetemeka mikono au miguu ambayo hukuweza kuizuia? 2. Have you ever had attacks in which you fall suddenly, without any reason, changing colour in the palms, lips or face?
Je, ulishawahi kupatwa na hali ambayo ilikufanya uanguke kubadilika rangi na kuwa mweupe kwenye viganja, midomo na usoni?? 3. Have you ever lost consciousness? Je, ulishawahi kupoteza fahamu? 4. Have you ever had attacks in which you fall with loss of consciousness?
Je, ulishawahi kupatwa na hali ambayo ilisababisha uanguke na kupoteza fahamu? 5. Have you ever had attacks in which you fall and bite your tongue?
Je, ulishawahi kupatwa na hali iliyokusababisha uanguke na kuuma/kung'ata ulimi wako? 6. Have you ever had attacks in which you fall and lose control of your bladder?
Je, ulishawahi kupatwa na hali ambayo ilikufanya uanguke na kutoa mkojo? 7. Have you ever had brief attacks of shaking or trembling in one arm or leg or in the face?
Je, ulishawahi kupatwa na hali ya muda mfupi ya kutetemeka au kutikisika mkono au mguu mmoja au kwenye uso? 8. Have you ever had attacks in which you lose contact with the surroundings and experience abnormal smells?
Je, ulishawahi kupatwa na hali ambayo ilikufanya upoteze ufahamu wa mahali ulipo na kusikia harufu zisizo za kawaida? 9. Have you ever been told that you have or had epilepsy or epileptic fits?
Je, ulishawahi kuelezwa kuwa una au ulishawahi kuwa na kifafa au kuanguka kifafa?
